Rhumbline Advisers Organogenesis Holdings Inc. Transaction History

Rhumbline Advisers

$121 Billion
Q3 2025

A detailed history of Rhumbline Advisers transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 102,530 shares of ORGO stock, worth $464,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,530

Previous 105,212 2.55%

Holding current value

$464,460

Previous $385,000 20.52%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$3.78 - $5.03 $10,137 - $13,490	-2,682 Reduced 2.55%	102,530 $464,000
Q2 2025 Aug 12, 2025	SELL	$2.66 - $5.34 $19,080 - $38,303	-7,173 Reduced 6.38%	105,212 $385,000
Q1 2025 Apr 08, 2025	SELL	$2.89 - $6.21 $8,326 - $17,891	-2,881 Reduced 2.5%	112,385 $505,000
Q4 2024 May 29, 2025	BUY	$2.77 - $4.43 $7,980 - $12,762	2,881 Added 2.56%	115,266 $368,000
Q4 2024 Jan 30, 2025	BUY	$2.77 - $4.43 $21,110 - $33,761	7,621 Added 7.08%	115,266 $368,000

Q3 2024 Nov 12, 2024	SELL	$2.42 - $3.24 $12,988 - $17,389	-5,367 Reduced 4.75%	107,645 $307,000
Q2 2024 Aug 01, 2024	BUY	$2.28 - $3.03 $7,834 - $10,411	3,436 Added 3.14%	113,012 $316,000
Q1 2024 May 09, 2024	BUY	$2.61 - $4.49 $8,224 - $14,147	3,151 Added 2.96%	109,576 $311,000
Q4 2023 Feb 08, 2024	SELL	$1.97 - $4.21 $2,029 - $4,336	-1,030 Reduced 0.96%	106,425 $435,000
Q3 2023 Nov 09, 2023	BUY	$2.34 - $4.43 $6,647 - $12,585	2,841 Added 2.72%	107,455 $341,000
Q2 2023 Aug 08, 2023	BUY	$1.9 - $4.3 $30,229 - $68,413	15,910 Added 17.94%	104,614 $347,000
Q1 2023 May 11, 2023	SELL	$1.89 - $2.93 $230,736 - $357,703	-122,083 Reduced 57.92%	88,704 $189,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $39,925 - $55,219	16,099 Added 8.27%	210,787 $567,000
Q3 2022 Nov 10, 2022	BUY	$3.14 - $6.43 $52,764 - $108,049	16,804 Added 9.45%	194,688 $631,000
Q2 2022 Aug 11, 2022	BUY	$4.74 - $8.15 $94,008 - $161,638	19,833 Added 12.55%	177,884 $868,000
Q1 2022 May 12, 2022	BUY	$6.47 - $9.57 $253,675 - $375,220	39,208 Added 32.99%	158,051 $1.2 Million
Q4 2021 Feb 10, 2022	BUY	$9.02 - $13.5 $31,398 - $46,993	3,481 Added 3.02%	118,843 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$13.71 - $17.18 $31,190 - $39,084	-2,275 Reduced 1.93%	115,362 $1.64 Million
Q2 2021 Aug 05, 2021	BUY	$14.92 - $23.23 $1.49 Million - $2.32 Million	99,993 Added 566.73%	117,637 $1.96 Million
Q1 2021 May 06, 2021	BUY	$7.33 - $21.06 $26,065 - $74,889	3,556 Added 25.24%	17,644 $321,000
Q4 2020 Feb 10, 2021	BUY	$3.63 - $7.53 $6,388 - $13,252	1,760 Added 14.28%	14,088 $106,000
Q3 2020 Nov 12, 2020	SELL	$3.29 - $4.58 $11,498 - $16,007	-3,495 Reduced 22.09%	12,328 $47,000
Q2 2020 Aug 13, 2020	BUY	$2.86 - $4.61 $45,253 - $72,944	15,823 New	15,823 $61,000

Others Institutions Holding ORGO

# of Institutions

127

Shares Held

70.2M

Call Options Held

39.7K

Put Options Held

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Organogenesis Holdings Inc. Transaction History